Deprescribing statins, considerations for informed decision making
Journal of the American Geriatrics Society · 2023-08 · 71 (8) · 2685-2689
DOI: 10.1111/jgs.18362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 21.04.2023. Verfasst von Craig Thomas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Sections, Departments of Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Deprescriptions, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Geriatrics Sections, Departments of Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Houston Methodist Hospital, Houston, Texas, USA.
ORCID-Profile: George E Taffet
Zitieren
APA
Thomas, C., Ellison, H., & Taffet, G. E. (2023). Deprescribing statins, considerations for informed decision making. Journal of the American Geriatrics Society, 71(8), 2685-2689. https://doi.org/10.1111/jgs.18362
Vancouver
Thomas C, Ellison H, Taffet GE. Deprescribing statins, considerations for informed decision making. Journal of the American Geriatrics Society. 2023;71(8):2685-2689. doi:10.1111/jgs.18362
BibTeX
@article{Thomas2023,
author = {Thomas, Craig and Ellison, Henry and Taffet, George E},
title = {Deprescribing statins, considerations for informed decision making},
journal = {Journal of the American Geriatrics Society},
year = {2023},
volume = {71},
number = {8},
pages = {2685--2689},
doi = {10.1111/jgs.18362}
}
EUVIMED